ARTICLE | Company News
PheneX AG, Lion bioscience deal
November 17, 2003 8:00 AM UTC
Nuclear receptor specialist PheneX acquired the assets that made up LIO's iD3 nuclear receptor drug discovery unit. LIO discontinued its iD3 group at the end of 2002. ...